Medicare AdvantagePrior AuthHigh impact
MA08.026o, Treatments for Complex Regional Pain Syndrome (CRPS)
Independence Blue Cross·Pain Management, Anesthesiology, Neurology +2 more·Medical Policy
Effective date
Aug 10, 2026
We identified it
Aug 11, 2026
Summary
Independence Blue Cross updated MA08.026o to add stricter coverage criteria for sympathetic nerve blocks in CRPS treatment. Providers must now demonstrate specific clinical benefits from prior blocks (decreased pain medication use, improved function, improved allodynia tolerance, 80% pain reduction, and 2°C temperature rise) before additional blocks beyond the initial three are approved. This effectively implements a new documentation and evidence requirement that may delay or deny reauthorization for continued treatment.
Action Required
By 2026-08-10: Billing and clinical teams must implement new prior authorization procedures for sympathetic nerve blocks (CPT 64510, 64520) in CRPS cases. Specifically: (1) Providers must document all five clinical benefit criteria after initial diagnostic block and again after three blocks before requesting authorization for blocks 4-6: decreased pain medication use, improved function (range of motion/strength/ADL use), improved allodynia/touch tolerance, 80% pain reduction sustained for anesthetic duration, and 2°C+ ipsilateral limb temperature rise. (2) Update prior authorization submission templates and EMR documentation requirements to include mandatory fields for these five objective measures. (3) Billing team must require these supporting documents before submitting reauthorization claims for blocks beyond the initial three; claims lacking this documentation will be denied. (4) Educate providers and clinical staff on the new evidence requirements and temperature/medication/function tracking needs. (5) Update billing software to flag any requests for sympathetic nerve blocks exceeding three per 12 months for manual review pending documentation of the five benefit criteria.